Charles River Laboratories International, Inc. (CRL)

CRL Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 30, 2023	Dec 31, 2022	Dec 25, 2021	Dec 26, 2020	Dec 28, 2019
Net Income	444.45	474.62	486.23	390.98	364.3	252.02
Depreciation & Amortization	322.41	314.12	303.87	265.54	234.92	198.1
Share-Based Compensation	75.33	72.05	73.62	71.47	56.34	57.27
Other Operating Activities	-137.79	-176.9	-244.07	32.8	-108.99	-26.45
Operating Cash Flow	704.4	683.9	619.64	760.8	546.58	480.94
Operating Cash Flow Growth	12.45%	10.37%	-18.55%	39.19%	13.65%	9.02%
Capital Expenditures	-290.8	-318.53	-324.73	-228.77	-166.56	-140.51
Acquisitions	-200.13	-249	-278.39	-1,215.96	-445.32	-538.04
Change in Investments	12.22	6.67	4.55	6.53	11.4	0.94
Other Investing Activities	-1.62	-2.29	-9.35	0.26	-1.07	-3.89
Investing Cash Flow	-480.33	-563.16	-607.92	-1,437.93	-601.54	-681.5
Share Issuance / Repurchase	20.82	1.44	-13.54	4.95	22.61	16.46
Debt Issued / Paid	-102.1	-75.32	19.79	669.98	30.59	227.28
Other Financing Activities	-11.14	-11.64	-48.65	-2.33	-5.95	-11.8
Financing Cash Flow	-92.42	-85.52	-42.4	672.6	47.25	231.94
Exchange Rate Effect	-2.01	8.04	25.58	17.73	0.79	11.36
Net Cash Flow	129.64	43.27	-5.1	13.2	-6.93	42.73
Free Cash Flow	413.61	365.37	294.91	532.03	380.02	340.42
Free Cash Flow Growth	50.27%	23.89%	-44.57%	40.00%	11.63%	13.06%
Free Cash Flow Margin	10.06%	8.85%	7.42%	15.03%	13.00%	12.99%
Free Cash Flow Per Share	8.04	7.13	5.80	10.58	7.67	6.99

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).